The University of Maryland School of Pharmacy (UMSOP) has been awarded $1.4 million from the Patient-Centered Outcomes Research Institute (PCORI) to advance how community voices are meaningfully engaged in health research.
Led by C. Daniel Mullins, PhD, professor in the Department of Practice, Sciences, and Health Outcomes Research and executive director of the PATIENTS Program at UMSOP, the two-year study is titled “Developing/Validating a Measure of CAB Engagement Outcomes from CAB Members’ Perspectives.” The goal is to develop a new, scientifically validated tool that measures Community Advisory Board members’ perspectives on how engagement affects trust, influence, and shared decision-making in patient-centered research.